<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04423432</url>
  </required_header>
  <id_info>
    <org_study_id>FUI/CTR/2020/4</org_study_id>
    <nct_id>NCT04423432</nct_id>
  </id_info>
  <brief_title>Effects of Creatine and Glucoseamine/ Chondritin Sulfate Co-Supplementation in Addition to Exercise and Physical Therapy in Patients With Knee Osteoarthritis</brief_title>
  <official_title>Effects of Creatine and Glucoseamine/ Chondritin Sulfate Co-Supplementation in Addition to Exercise and Physical Therapy in Patients With Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foundation University Islamabad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Isra University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Foundation University Islamabad</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis is the 11th highest contributor to disability world wide. In terms of
      conservative management of patients with knee osteoarthritis, Resistance exercise has been
      shown to be an effective intervention for reducing pain and cartilage degeneration and
      improving muscle strength, joint biomechanics and physical functioning. But, research shows
      that co supplementation can further augment the effects of resistance exercise. However, it
      is imperative to point out that the existing evidence is majorly focused on the individual
      effects of resistance exercise training and non-pharmacological supplementation, and is still
      deficient in the effects of co-supplementation in addition to resistance exercise training in
      patients with knee osteoarthritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Pain: Numeric Pain Rating Scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>Knee Pain will be quantified by using Numeric Pain Rating Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Range of Motion</measure>
    <time_frame>4 weeks</time_frame>
    <description>Knee Range of Motion will be quantified by using Gonimeter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Isometric Muscle Strength</measure>
    <time_frame>4 weeks</time_frame>
    <description>Knee Isometric Muscle Strength will be quantified by using Modified Sphygmomanometer Dynamometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six Minute Walk Test</measure>
    <time_frame>4 weeks</time_frame>
    <description>Six Minute Walk Test will be used to quantify walking related performance fatigability, walkind distance and walking speed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>4 weeks</time_frame>
    <description>The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition</measure>
    <time_frame>4 weeks</time_frame>
    <description>Body Composition will be quantified by using Bioelectrical Impedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fall Risk</measure>
    <time_frame>4 weeks</time_frame>
    <description>Fall risk will be quantified by using Biodex balance System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural Stability</measure>
    <time_frame>4 weeks</time_frame>
    <description>Postural Stability will be quantified by using Biodex balance System</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lower Extremity Resistance Exercise Training</intervention_name>
    <description>3 times supervised exercise for 4 weeks Warm up (Self Paced walking for 10 minutes) leg press (8-12 RM) leg extension (8-12 RM) Sit to stand squat (with weight) Stationary Cycling (Maximum Resistance as per patient tolerance till failure)</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
    <other_name>Lower Extremity Strength Training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home Exercise Plan</intervention_name>
    <description>2 sets of 10 repetitions/day of
AROM isolated knee extension and knee flexion
Isometric isolated knee extension and knee flexion
Isometric terminal knee extension
Sit to stand squat
terminal extension as Home Exercise Program (HEP). (Iwamoto J et al, 2007)</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrotherapy + Heating</intervention_name>
    <description>Iinterferential Current therapy (2P), in combination with heating pad for 20 minutes</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Joint Mobilization</intervention_name>
    <description>Tibio-femoral Anterior Glide
Tibio-femoral Posterior Glide
Patellofemoral Joint Mobilization</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
    <other_name>Manual Therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine Supplementation</intervention_name>
    <description>Creatine Supplementation 20g/day for 1 week followed by 5 g/day for 3 weeks</description>
    <arm_group_label>Creatine Supplementation</arm_group_label>
    <other_name>Creatine Monohydrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucoseamine/ Chondritin Sulfate Supplementation</intervention_name>
    <description>Glucoseamine/ Chondritin Sulfate Supplementation (500mg+400mg/day)</description>
    <arm_group_label>Glucoseamine/ Chondritin Sulfate Supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40-70 years

          -  Knee OA with history not less than three months.

          -  Radiological evidences of grade III or less on Kellgren classification.

          -  Knee pain on VNRS no more than 8/10

        Exclusion Criteria:

          -  Neuromuscular conditions that may lead to fatigue such as multiple Sclerosis

          -  Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection).

          -  History of trauma or fractures in lower extremity.

          -  Signs of lumbar radiculopathy or myelopathy.

          -  History of knee surgery or replacement.

          -  Patients on intra-articular steroid therapy within two months before the commencement
             of the study.

          -  Impaired skin sensation.

          -  Impaired renal function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad Osama, PhD*</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foundation University Institute of Rehabilitation Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muhammad Osama, PhD*</last_name>
    <phone>+923325540436</phone>
    <email>osamadpt@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Foundation University Institute of Rehabilitation Sciences</name>
      <address>
        <city>Islamabad</city>
        <state>Federal</state>
        <zip>45710</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Osama</last_name>
      <phone>03325540436</phone>
      <email>osamadpt@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Muhammad Osama, PhD*</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 5, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

